SciELO - Scientific Electronic Library Online

 
vol.102 issue6 author indexsubject indexarticles search
Home Pagealphabetic serial listing  

SAMJ: South African Medical Journal

Print version ISSN 0256-9574

Abstract

HANEKOM, Willem A et al. SATVI: after 10 years closing in on a new and better vaccine to prevent tuberculosis. SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.6, pp. 438-441. ISSN 0256-9574.

The vision of the South African Tuberculosis Vaccine Initiative (SATVI) (http://www.satvi.uct.ac.za) is 'A World Without TB' and our mission is 'Innovative and high-quality TB vaccine research in Africa, to impact the global epidemic'. Over the last 10 years, our focus has been two-fold: first, clinical trials of BCG and of new candidate vaccines, and second, complementary research that addresses critical questions in tuberculosis (TB) vaccine development. SATVI is now widely regarded as the leading TB vaccine clinical research site in the world.

        · text in English     · pdf in English